For the year ending 2025-12-31, REVB has $11,582,924 in assets. $2,721,929 in debts. $10,700,331 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 10,700,331 | |||
| Prepaid expenses and other current assets | 111,297 | |||
| Total current assets | 10,811,628 | |||
| Property and equipment, net | 18,067 | |||
| Operating lease right-of-use asset | 722,288 | |||
| Other assets | 30,941 | |||
| Total assets | 11,582,924 | |||
| Accounts payable | 577,501 | |||
| Accrued expenses | 1,397,644 | |||
| Operating lease liability | 23,013 | |||
| Total current liabilities | 1,998,158 | |||
| Operating lease liability, net of current portion | 723,771 | |||
| Total liabilities | 2,721,929 | |||
| Common stock, 0.001 par value 500,000,000 shares authorized at december 31, 2025 and december 31, 2024 and 1,583,969 and 43,526 issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 1,584 | |||
| Additional paid-in-capital | 58,278,698 | |||
| Accumulated deficit | -49,419,287 | |||
| Total stockholders' equity | 8,860,995 | |||
| Total liabilities and stockholders' equity | 11,582,924 | |||
REVELATION BIOSCIENCES, INC. (REVB)
REVELATION BIOSCIENCES, INC. (REVB)